← Leaderboards
Peisheng Xu
University Of South Carolina At Columbia
$5,773,962
Attributed
$6,222,231
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $976.1K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,222,231 · 8
By mechanism
R01$3,161,579 · 2
R41$1,191,872 · 3
P20$1,105,433 · 1
R21$397,097 · 1
R15$366,250 · 1
Top collaborators
- Hexin Chen2 shared
- Daping Fan1 shared
Most similar at University Of South Carolina At Columbia
Same institution · by research overlap
- Baoting Zhu$3,069,030
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposSuccessPharmaceutical PreparationsCellsNanoparticleIn VivoPolymersDrug KineticsPropertyOxidation-ReductionMouse ModelIn VitroBaseDensityMalignant NeoplasmsMaximum Tolerated DoseSystemic ToxicityToxic EffectImmune ResponseUnited StatesInhibitor/AntagonistCancer CellMetalsExhibits
Grant awards (20)
Cancer cell selective killing nanoparticle for advanced ovarian cancer treatment$338,506
R01 · FY2025 · CA · contact PI
Develop a novel strategy to deliver N-acetylcysteine for AD treatment$499,441
R41 · FY2024 · AG · contact PI
Cancer cell selective killing nanoparticle for advanced ovarian cancer treatment$321,581
R01 · FY2024 · CA · contact PI
Cancer cell selective killing nanoparticle for advanced ovarian cancer treatment$331,736
R01 · FY2023 · CA · contact PI
Cancer cell selective killing nanoparticle for advanced ovarian cancer treatment$338,506
R01 · FY2022 · CA · contact PI
The development of a multifunctional nanoenzyme for AD treatment$299,628
R41 · FY2022 · AG · contact PI
A novel polymer-metal nanocomplex for ovarian cancer treatment$392,803
R41 · FY2021 · CA · contact PI
Brain targeted nanoparticle for Alzheimer's disease therapy$366,250
R01 · FY2021 · AG · contact PI
Nanoparticle delivered miR-489 rejuvenates anthracycline-based chemotherapy$217,080
R21 · FY2021 · CA
Brain targeted nanoparticle for Alzheimer's disease therapy$366,250
R01 · FY2020 · AG · contact PI
Nanoparticle delivered miR-489 rejuvenates anthracycline-based chemotherapy$180,017
R21 · FY2020 · CA
Brain targeted nanoparticle for Alzheimer's disease therapy$366,250
R01 · FY2019 · AG · contact PI
Brain targeted nanoparticle for Alzheimer's disease therapy$366,250
R01 · FY2018 · AG · contact PI
Dual responsive nanoparticle for brain targeted drug delivery$219,750
P20 · FY2018 · GM · contact PI
Brain targeted nanoparticle for Alzheimer's disease therapy$366,250
R01 · FY2017 · AG · contact PI
Dual responsive nanoparticle for brain targeted drug delivery$222,223
P20 · FY2017 · GM · contact PI
Dual responsive nanoparticle for brain targeted drug delivery$223,960
P20 · FY2016 · GM · contact PI
Nano-cocktail overcomes multidrug-resistance for ovarian cancer therapy$366,250
R15 · FY2015 · CA · contact PI
Dual responsive nanoparticle for brain targeted drug delivery$219,750
P20 · FY2015 · GM · contact PI
Dual responsive nanoparticle for brain targeted drug delivery$219,750
P20 · FY2014 · GM · contact PI